The results of in vivo and in vitro experiments in this study showed, for the first time, that SMOC2 expression was intimately correlated with the malignant progression of pancreatic cancer and that SMOC2 played a cancer-promoting effect. The gene discussed is SMOC2; the disease is familial pancreatic carcinoma.